Wednesday, June 13, 2012
See below for a list of the scheduled events for the Wisconsin pavilion at this year's BIO Convention in Boston.
Monday, June 18
2:00 p.m., Exact Sciences, Kevin Conroy, CEO Advancement in non-invasive colorectal cancer screening.
3:00 p.m., InvivoSciences, Tetsuro Wakatsuki Ph.D., Chief Scientific Officer, Co-Founder Technology of tissue constructs fabricated using human cells to predict compound response in clinical trials.
4:00 p.m., Super Vitamin D, Ted Schwarzrock and John Stapleton Advancement for delivery of Vitamin D through the skin.
Tuesday, June 19
10:00 a.m., Shine Medical Technologies and Morgridge Institute for Research, Dr. Greg Piefer, founder and CEO of SHINE Medical Technologies and Thomas Rock Mackie, Director of Medical Devices at the Morgridge Institute for Research Partnership to develop a new production technology for a medical isotope commonly used to diagnose heart disease and cancer and in short supply for tens of thousands of U.S. patients.
4:15 p.m. Quintessence Biosciences, Dr. Laura Strong and EVade™ Ribonuclease Technology which allows for the engineering of human proteins for the treatment of human diseases. http://www.quintbio.com
Wednesday, June 20
11:00 a.m., Marshfield Clinic Applied Sciences, Marsha L. Barwick, Assistant Director, with a presentation on the Wisconsin Medical Entrepreneurship Foundation business model that allows partners, Aurora Health Care, Baycare Health Care, Marshfield Clinic and WiSys Technology Foundation to collectively leverage extramural funding and resources towards technology advancement.
4:30 p.m. The Computational Genome: Informational Insights into the Cell, David Krakauer, Director, Wisconsin Institute for Discovery